Vor Biopharma Inc.
Price Action
Technical Summary
EMERGING TRENDVor Biopharma Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 60), indicating performance broadly in line with the market. Earnings contraction of 97% provides fundamental context to the price action. However, price is extended 25% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $14.44 | +28.83% | ABOVE |
| 50 SMA | $14.84 | +25.35% | ABOVE |
| 100 SMA | $14.68 | +26.67% | ABOVE |
| 150 SMA | $13.91 | +33.76% | ABOVE |
| 200 SMA | $17.22 | +8.00% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is VOR in an uptrend right now?
VOR has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is VOR overbought or oversold?
VOR's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.
Is VOR outperforming the market?
VOR has a Relative Strength (RS) Rating of 60 out of 99. VOR is performing about average compared to the market.
Where is VOR in its 52-week range?
VOR is trading at $18.60, which is 28% of its 52-week high ($65.80) and 20% above its 52-week low ($6.50).
How volatile is VOR?
VOR has a Beta of 1.15 and 52-week volatility of 137%. It's more volatile than the S&P 500 - expect bigger swings.